Gobbi Novag is a finished-dose manufacturer based in Argentina. It appears in 46 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANMAT (AR) and MINSA (CR). Customs aggregates show $1.6M of exports covering 54 molecules to 5 destinations in 2025.
| Site | FDA FEI |
|---|---|
| BUENOS AIRES, Argentina | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANMAT (AR) | 44 | None |
| MINSA (CR) | 2 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $1.6M | 5 |
| 2024 | Not reported | $598K | 5 |
| 2023 | Not reported | $466K | 6 |
| 2022 | Not reported | $536K | 3 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Gobbi Novag comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.